Evidence map›Paper›PMID 35781871›Full record

ArticleActa psychiatrica Scandinavica2022

Characteristics and predictors of off-label use of antipsychotics in general population sample.

Eero Pirhonen, Marianne Haapea, Nina Rautio, Tanja Nordström, Miia Turpeinen, Outi Laatikainen, Hannu Koponen, Jenni Silvan, Jouko Miettunen, Erika Jääskeläinen

Open access · hybridAbstract read
In one paragraph

Article in Acta psychiatrica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Eero PirhonenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Marianne HaapeaCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Nina RautioCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Tanja NordströmCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Miia TurpeinenResearch Unit of Biomedicine, Medical Research Center Oulu and Oulu University Hospital, University of Oulu, Oulu, Finland.
Outi LaatikainenResearch Unit of Biomedicine, Medical Research Center Oulu and Oulu University Hospital, University of Oulu, Oulu, Finland.
Hannu KoponenHelsinki University Hospital, Psychiatry, University of Helsinki, Helsinki, Finland.
Jenni SilvanCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Jouko MiettunenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Erika JääskeläinenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
University of Oulu · FIOulu University Hospital · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIncreasing number of people have been prescribed antipsychotics (APs) off-label in recent decades. This study aimed to identify the characteristics and predictors of receiving prescription of antipsychotics off-label.

methodsThe study sample was part of the Northern Finland Birth Cohort 1966 (n = 7071). Data included questionnaires and national register data. Information on prescribed medications was extracted from the national register. The sample was divided into three groups: Persons who had been prescribed APs off-label (n = 137), individuals with non-psychotic mental disorders without APs off label (n = 1478) and individuals who had been diagnosed with psychosis or bipolar disorder and who had been prescribed APs (n = 151). We compared sociodemographic, lifestyle and clinical characteristics between the off-label and the comparison groups using logistic regression.

resultsThe most common diagnoses in the off-label group were depression (n = 96, 70.1%) and anxiety (n = 55, 40.1%). Compared with individuals with non-psychotic mental disorders who were not prescribed APs off-label, individuals with prescribed off-label APs had a lower level of education, lower socioeconomic status, were less often married, had a higher level of somatic and psychiatric morbidity, were more often smokers and more often had a substance abuse disorder and heavy alcohol consumption. When comparing the off-label group to individuals with psychosis or bipolar disorder who used APs, there were less differences, though individuals with psychosis or bipolar disorder had more markers of morbidity and a lower level of education.

conclusionIndividuals who had been prescribed APs off label had a higher level of mental and somatic morbidity and poorer socioeconomic status than individuals with non-psychotic mental disorders who did not use APs.

Indexed as

Antipsychotic AgentsBipolar DisorderPsychotic DisordersHumansOff-Label UseSurveys and QuestionnairesAntipsychotic Agentsantipsychotic agentcomorbiditymental disordersoff-label usesocioeconomic status

Identifiers

PMID35781871
PMCPMC9543108
OpenAlexW4283791186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.